| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Monicque M Lorist, Maarten A S Boksem, K Richard Ridderinkho. Impaired cognitive control and reduced cingulate activity during mental fatigue. Brain research. Cognitive brain research. vol 24. issue 2. 2005-08-30. PMID:15993758. |
findings that (1) mental fatigue is associated with compromised performance monitoring and inadequate performance adjustments after errors, (2) monitoring functions of acc and striatum rely on dopaminergic inputs from the midbrain, and (3) patients with striatal dopamine deficiencies show symptomatic mental fatigue, suggest that mental fatigue results from a failure to maintain adequate levels of dopaminergic transmission to the striatum and the acc, resulting in impaired cognitive control. |
2005-08-30 |
2023-08-12 |
Not clear |
| Panagiotis Giompres, Foteini Deli. Dopamine transporters in the cerebellum of mutant mice. Cerebellum (London, England). vol 4. issue 2. 2005-08-30. PMID:16035192. |
although the cerebellum plays a role in the control of movement and posture and in cognitive functions, it has not been considered to be a dopaminergic region and the dopamine present was thought to represent a precursor of noradrenaline. |
2005-08-30 |
2023-08-12 |
mouse |
| D J Lodge, A A Grac. Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity. The Journal of pharmacology and experimental therapeutics. vol 314. issue 1. 2005-08-26. PMID:15784652. |
based on the large amount of literature demonstrating an association between dopaminergic neurotransmission and reward-related behavior, the aim of the present study was to examine the effects of acute versus chronic crf1 receptor blockade on mesencephalic dopamine (da) neuron activity (determined by in vivo extracellular recordings) and extracellular da levels in the nucleus accumbens (acb) (using in vivo microdialysis). |
2005-08-26 |
2023-08-12 |
Not clear |
| Johan P Rung, Arvid Carlsson, Katarina Rydén Markinhuhta, Maria L Carlsso. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 29. issue 5. 2005-08-26. PMID:15916843. |
dopaminergic agonists and nmda-receptor antagonists form the basis for the dopamine and glutamate models of schizophrenia, respectively. |
2005-08-26 |
2023-08-12 |
human |
| Katherine Widnel. Pathophysiology of motor fluctuations in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 20 Suppl 11. 2005-08-25. PMID:15822108. |
this body of preclinical data suggests that nonphysiological, pulsatile stimulation of dopamine receptors induces the development of motor fluctuations and dyskinesias and raises the possibility that nonpulsatile stimulation of dopamine receptors (continuous dopaminergic stimulation) might induce fewer fluctuations. |
2005-08-25 |
2023-08-12 |
Not clear |
| Claudia Trenkwalder, Walter Paulus, Arthur S Walter. The restless legs syndrome. The Lancet. Neurology. vol 4. issue 8. 2005-08-25. PMID:16033689. |
dopaminergic treatment with levodopa and dopamine agonists is the first choice in idiopathic restless legs syndrome, but augmentation and rebound should be monitored in long-term treatment. |
2005-08-25 |
2023-08-12 |
Not clear |
| B Jakobsen, J B Gramsbergen, A Møller Dall, C Rosenblad, J Zimme. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF. The European journal of neuroscience. vol 21. issue 11. 2005-08-24. PMID:15978005. |
we characterized organotypic ventral mesencephalic (vm) cultures derived from embryonic day 12 (e12) mice (cbl57/bl6) in terms of number of dopaminergic neurons, cell soma size and dopamine production in relation to time in vitro and tested the effects of 1-methyl-4-phenylpyridinium (mpp(+)) and glial derived neurotrophic factor (gdnf) to validate this novel culture model. |
2005-08-24 |
2023-08-12 |
mouse |
| Frédéric Moret, Lionel Christiaen, Carole Deyts, Maryline Blin, Jean-Stéphane Joly, Philippe Vernie. The dopamine-synthesizing cells in the swimming larva of the tunicate Ciona intestinalis are located only in the hypothalamus-related domain of the sensory vesicle. The European journal of neuroscience. vol 21. issue 11. 2005-08-24. PMID:15978015. |
as dopaminergic cells are specified in the hypothalamus in all vertebrates, we suggest that the mechanisms of dopamine cell specification are conserved in the hypothalamus of ciona and vertebrates. |
2005-08-24 |
2023-08-12 |
Not clear |
| S Rossi, S Singer, E Shearman, H Sershen, A Lajth. The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes. Neurochemical research. vol 30. issue 4. 2005-08-24. PMID:16076024. |
in a continuing study of nicotine-induced mechanisms in brain areas associated with cognitive processes, the effects of cholinergic and dopaminergic antagonists on nicotine-induced changes in dopamine, norepinephrine, and serotonin were examined. |
2005-08-24 |
2023-08-12 |
rat |
| S Rossi, S Singer, E Shearman, H Sershen, A Lajth. The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes. Neurochemical research. vol 30. issue 4. 2005-08-24. PMID:16076024. |
nicotine-induced dopamine increases were inhibited by nicotinic (mecamylamine 100 microm, methyllycaconitine 500 microm), muscarinic (atropine 100 microm), and dopaminergic d1 (sch23390 100 microm) and d2 (eticlopride 100 microm) antagonists, in the hippocampal and cortical areas. |
2005-08-24 |
2023-08-12 |
rat |
| S Rossi, S Singer, E Shearman, H Sershen, A Lajth. The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes. Neurochemical research. vol 30. issue 4. 2005-08-24. PMID:16076024. |
nicotine-induced dopamine release seems to be mediated, in part locally, by nicotinic and muscarinic receptors on dopaminergic cells. |
2005-08-24 |
2023-08-12 |
rat |
| Olle Lindvall, Anders Björklun. Cell therapy in Parkinson's disease. NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics. vol 1. issue 4. 2005-08-23. PMID:15717042. |
the grafted dopaminergic neurons can reinnervate the denervated striatum, restore regulated dopamine (da) release and movement-related frontal cortical activation, and give rise to significant symptomatic relief. |
2005-08-23 |
2023-08-12 |
Not clear |
| Angela Pignatelli, Kazuto Kobayashi, Hideyuki Okano, Ottorino Belluzz. Functional properties of dopaminergic neurones in the mouse olfactory bulb. The Journal of physiology. vol 564. issue Pt 2. 2005-08-23. PMID:15731185. |
dopamine has been shown both in vivo and in vitro to modulate several aspects of olfactory information processing, but the functional properties of dopaminergic neurones have never been described due to the inability to recognize these cells in living preparations. |
2005-08-23 |
2023-08-12 |
mouse |
| Tom N Grammatopoulos, Ferogh Ahmadi, Susan M Jones, Marc W Fariss, James A Weyhenmeyer, W Michael Zawad. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death. Brain research. vol 1045. issue 1-2. 2005-08-18. PMID:15910763. |
here, we show that acute exposure of vm cultures to the pesticide rotenone leads to dopaminergic neuronal cell death and that angiotensin acting through the at2 receptor protects dopamine neurons from rotenone toxicity. |
2005-08-18 |
2023-08-12 |
rat |
| Marie Vandecasteele, Jacques Glowinski, Laurent Venanc. Electrical synapses between dopaminergic neurons of the substantia nigra pars compacta. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 25. issue 2. 2005-08-17. PMID:15647472. |
spatiotemporal properties of dopamine release play a major role both in striatal and nigral physiology because dopamine is released from nerve terminals and dendrites of nigrostriatal dopaminergic (da) neurons. |
2005-08-17 |
2023-08-12 |
rat |
| Satoshi Fuke, Noboru Sasagawa, Shoichi Ishiur. Identification and characterization of the Hesr1/Hey1 as a candidate trans-acting factor on gene expression through the 3' non-coding polymorphic region of the human dopamine transporter (DAT1) gene. Journal of biochemistry. vol 137. issue 2. 2005-08-16. PMID:15749835. |
expression of the dopamine transporter (dat) gene affects dopaminergic neurotransmission. |
2005-08-16 |
2023-08-12 |
human |
| Eun-Sook Y Lee, Hongtao Chen, Karam F A Soliman, Clivel G Charlto. Effects of homocysteine on the dopaminergic system and behavior in rodents. Neurotoxicology. vol 26. issue 3. 2005-08-12. PMID:15935208. |
following homocysteine injection the locomotor activities, the levels of dopamine (da) and its metabolites, 3,4-dihydroxyphenylacetic acid (dopac) and homovanillic acid (hva), and immunohistochemistry of dopaminergic neurons were examined. |
2005-08-12 |
2023-08-12 |
mouse |
| Elena H Chartoff, Carrie L Heusner, Richard D Palmite. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 30. issue 7. 2005-08-09. PMID:15688082. |
we used dopamine-deficient (dd) mice in which tyrosine hydroxylase is selectively inactivated in dopaminergic neurons to determine whether dopamine is required for the locomotor and molecular effects of pcp and mk-801. |
2005-08-09 |
2023-08-12 |
mouse |
| Philippe Brun, Mélina Bégou, Annie Andrieux, Laurence Mouly-Badina, Magali Clerget, Annie Schweitzer, Hélène Scarna, Bernard Renaud, Didier Job, Marie-Françoise Suaud-Chagn. Dopaminergic transmission in STOP null mice. Journal of neurochemistry. vol 94. issue 1. 2005-08-08. PMID:15953350. |
when measured by electrochemical techniques, the dopamine efflux evoked by electrical stimulations mimicking physiological stimuli was dramatically increased in the nucleus accumbens of stop null mice, apparently due to an increased dopamine release, whereas dopaminergic uptake and auto-inhibition mechanisms were normal. |
2005-08-08 |
2023-08-12 |
mouse |
| E Sherwood Brown, Jala Jeffress, Joshua D M Liggin, Monica Garza, Laura Bear. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole. The Journal of clinical psychiatry. vol 66. issue 6. 2005-08-04. PMID:15960570. |
dopamine release is implicated in substance use, and both dopaminergic agonists and antagonists have been examined for the treatment of substance abuse. |
2005-08-04 |
2023-08-12 |
Not clear |